Zidebactam dihydrate

Investigational

Details

Stereochemistry	ABSOLUTE
Molecular Formula	C13H21N5O7S.2H2O
Molecular Weight	427.431
Optical Activity	UNSPECIFIED
Defined Stereocenters	4 / 4
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

O.O.OS(=O)(=O)ON1[C@H]2C[N@]([C@@H](CC2)C(=O)NNC(=O)[C@@H]3CCCNC3)C1=O

InChI

InChIKey=JMMRGZPABAFUJE-XYSAUEOZSA-N

InChI=1S/C13H21N5O7S.2H2O/c19-11(8-2-1-5-14-6-8)15-16-12(20)10-4-3-9-7-17(10)13(21)18(9)25-26(22,23)24;;/h8-10,14H,1-7H2,(H,15,19)(H,16,20)(H,22,23,24);2*1H2/t8-,9-,10+;;/m1../s1

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28289035 | https://clinicaltrials.gov/ct2/show/NCT02674347

Zidebactam (also known as WCK 5107), a beta-lactam enhancer that belongs to the bicyclo-acyl hydrazide series. This drug inhibits the penicillin-binding protein and is participating in phase I clinical trial to treat the bacterial infection.

Originator

Approval Year

PubMed

Title	Date	PubMed
WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent "β-Lactam Enhancer" Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones.	2017-06	28289035

Patents

Sample Use Guides

In Vivo Use Guide

3 g of zidebactam (1 g q8h) and 6 g of cefepime (2 g q8h) or 6 administered as IV infusions every q8h, over a period of 60 minutes.

Route of Administration: Intravenous

Name

Type

Language

1,6-Diazabicyclo[3.2.1]octane-2-carboxylic acid, 7-oxo-6-(sulfooxy)-, 2-[2-[(3R)-3-piperidinylcarbonyl]hydrazide], hydrate (1:2), (1R,2S,5R)-

Preferred Name

English

Zidebactam dihydrate

Common Name

English

Code System Code Type Description

PUBCHEM

156613482

Created by admin on Wed Apr 02 16:34:44 GMT 2025 , Edited by admin on Wed Apr 02 16:34:44 GMT 2025

PRIMARY

CAS

1996664-59-5

Created by admin on Wed Apr 02 16:34:44 GMT 2025 , Edited by admin on Wed Apr 02 16:34:44 GMT 2025

PRIMARY

FDA UNII

TE54T8WC4T

Created by admin on Wed Apr 02 16:34:44 GMT 2025 , Edited by admin on Wed Apr 02 16:34:44 GMT 2025

PRIMARY

ACTIVE MOIETY


					YPM97423DB

ZIDEBACTAM

SUBSTANCE RECORD


					TE54T8WC4T

Zidebactam dihydrate

Details

SMILES

InChI

DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/28289035 | https://clinicaltrials.gov/ct2/show/NCT02674347

Originator

Approval Year

PubMed

Patents

Sample Use Guides

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28289035 | https://clinicaltrials.gov/ct2/show/NCT02674347